The considerably less-most likely alternate would be the Dutch product, where production and distribution wouldn't be under the purview with the Condition, although the drug would continue to be taxed.[55] For a consequence, the cultivation, marketing, and sale of the ultimate solutions could well be left on the private sector, resulting in the est